e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Cystic fibrosis lung disease: pieces of the puzzle
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New proteomic biomarkers of cystic fibrosis: a comparison with non-CF bronchiectasis
R. D. Gray, M. Imrie, G. MacGregor, M. Dewar, A. C. Boyd, J. A. Innes, D. Porteous, A. P. Greening (Edinburgh, United Kingdom)
Source:
Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Session:
Cystic fibrosis lung disease: pieces of the puzzle
Session type:
Oral Presentation
Number:
1633
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. D. Gray, M. Imrie, G. MacGregor, M. Dewar, A. C. Boyd, J. A. Innes, D. Porteous, A. P. Greening (Edinburgh, United Kingdom). New proteomic biomarkers of cystic fibrosis: a comparison with non-CF bronchiectasis. Eur Respir J 2005; 26: Suppl. 49, 1633
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
Phenotype characterization of non-cystic fibrosis bronchiectasis in India.
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017
NTM in cystic fibrosis and non-CF bronchiectasis
Source: ERS Course 2015
Year: 2015
Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012
Inflammatuary markers in induced sputum and clinical parameters in children with non-cystic fibrosis bronchiectasis
Source: Annual Congress 2004 - Chronic respiratory illness in childhood
Year: 2004
The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2019; 83: 158-172
Year: 2019
Comparison of EBC biomarkers in cystic fibrosis and bacterial pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006
The pulmonary microbiome in non-cystic fibrosis bronchiectasis.
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017
Immuno-allertypes in non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 181-198
Year: 2017
Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 38-57
Year: 2017
Non-cystic fibrosis bronchiectasis
Source: International Congress 2019 – Recent clinical advances in inhalation therapy
Year: 2019
Non-cystic fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020
Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring
Source: Eur Respir J 2006; 28: Suppl. 50, 152s
Year: 2006
Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018
A molecular comparison of microbial communities in bronchiectasis and cystic fibrosis
Source: Eur Respir J 2013; 41: 991-993
Year: 2013
Cystic fibrosis patients have different microbiological colonization comparing to other bronchiectasis
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010
Non-cystic fibrosis bronchiectasis: series of 89 patients
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Non-cystic fibrosis bronchiectasis in children
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept